Search

Author/Creator Beauverger, Philippe

2. Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy. Issue 2 (8th April 2019)

Authors:
Beauverger, Philippe; Ozoux, Marie-Laure; Bégis, Guillaume; Glénat, Valérie; Briand, Véronique; Philippo, Marie-Claire; Daveu, Cyril; Tavares, Georges; Roy, Sébastien; Corbier, Alain; Briand, Pascale; Dorchies, Olivier; Bauchet, Anne-Laure; Nicolai, Eric; Duclos, Olivier; Tamarelle, Dorothée; Pru...
Journal:
Cardiovascular research
Issue:
Volume 116:Issue 2(2020)
Page Start:
329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The oral Ca/calmodulin‐dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure. (20th July 2020)

Authors:
Mustroph, Julian; Drzymalski, Marzena; Baier, Maria; Pabel, Steffen; Biedermann, Alexander; Memmel, Bernadette; Durczok, Melanie; Neef, Stefan; Sag, Can Martin; Floerchinger, Bernhard; Rupprecht, Leopold; Schmid, Christof; Zausig, York; Bégis, Guillaume; Briand, Veronique; Ozoux, Marie‐Laure; Tam...
Journal:
ESC heart failure
Issue:
Volume 7:Number 5(2020)
Page Start:
2871
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy. Issue 3 (16th March 2022)

Authors:
Reisqs, Jean‐Baptiste; Moreau, Adrien; Charrabi, Azzouz; Sleiman, Yvonne; Meli, Albano C.; Millat, Gilles; Briand, Veronique; Beauverger, Philippe; Richard, Sylvain; Chevalier, Philippe
Journal:
Clinical and translational medicine
Issue:
Volume 12:Issue 3(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗